Dana Farber and 454 life sciences announce breakthrough in DNA sequencing

454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation, in collaboration with scientists at Dana Farber Cancer Center and Broad Institute, today reported a new method for the detection of cancer gene mutations present at extremely low levels.

It is heartwarming to see that the scientific community is working ever closer to curing cancer. I just wish they could have saved my aunt from dying of breast cancer. :/

read more | digg story

This entry was posted in Uncategorized. Bookmark the permalink.

This website uses IntenseDebate comments, but they are not currently loaded because either your browser doesn't support JavaScript, or they didn't load fast enough.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Additional comments powered by BackType